These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9868123)

  • 21. Correlation of metabolic syndrome with residual renal function, solute transport rate and peritoneal solute clearance in chronic peritoneal dialysis patients.
    Chen HY; Kao TW; Huang JW; Chu TS; Wu KD
    Blood Purif; 2008; 26(2):138-44. PubMed ID: 18212496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal incontinence secondary to CAPD.
    Sorin V; Ron Y; Smetana S; Avni Y
    Am J Kidney Dis; 2003 Jan; 41(1):E2. PubMed ID: 12500212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peritoneal protein losses in diabetic patients starting peritoneal dialysis: is there a relationship with diabetic vascular lesions?
    Coronel F; Cigarrán S; Herrero JA; Delgado J; Ramos F; Gomis A
    Adv Perit Dial; 2009; 25():115-8. PubMed ID: 19886331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors influencing peritoneal transport parameters during the first year on peritoneal dialysis: peritonitis is the main factor.
    del Peso G; Fernández-Reyes MJ; Hevia C; Bajo MA; Castro MJ; Cirugeda A; Sánchez-Tomero JA; Selgas R
    Nephrol Dial Transplant; 2005 Jun; 20(6):1201-6. PubMed ID: 15827050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental study of the effect of danshen on the viability of burned skin].
    Hu J; Ren L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1998 Jul; 12(4):205-8. PubMed ID: 10437067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Peritoneal equilibrium test with hypertonic exchange: practical application in a peritoneal dialysis program].
    Ortiz A; Marrón B; Berlanga JR; Reyero A; Gazapo R
    Nefrologia; 2001; 21(4):362-9. PubMed ID: 11816512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome for continuous ambulatory peritoneal dialysis patients is not predicted by peritoneal permeability characteristics.
    Passadakis PS; Thodis ED; Panagoutsos SA; Selisiou CA; Pitta EM; Vargemezis VA
    Adv Perit Dial; 2000; 16():2-6. PubMed ID: 11045251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between arterial stiffness and peritoneal small solute transport rate.
    Zhe XW; Tian XK; Chen W; Guo LJ; Gu Y; Chen HM; Tang LJ; Wang T
    Artif Organs; 2008 May; 32(5):416-9. PubMed ID: 18471172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
    Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
    Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications?
    Wang AY; Woo J; Sea MM; Law MC; Lui SF; Li PK
    Am J Kidney Dis; 2004 Apr; 43(4):712-20. PubMed ID: 15042549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Extended assessment of peritoneal transport kinetics of substances and water as an important element of integrated dialysis care].
    Baczyński D; Antosiewicz S; Waniewski J; Marciniak M; Wańkowicz Z
    Pol Merkur Lekarski; 2004 Aug; 17(98):110-3. PubMed ID: 15603317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Structure of dihydroisotanshinone I of danshen].
    Kong DY; Liu XJ
    Yao Xue Xue Bao; 1984 Oct; 19(10):755-9. PubMed ID: 6549557
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of injection Salvia miltiorrhizae on peritoneal dialysis].
    Xu ZC
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Feb; 13(2):74-6, 67. PubMed ID: 8334340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapeutic effect of danshen injection on chronic active hepatitis].
    Bai YL
    Zhong Xi Yi Jie He Za Zhi; 1984 Feb; 4(2):86-7. PubMed ID: 6235048
    [No Abstract]   [Full Text] [Related]  

  • 38. An overview of nephrology in China.
    Li LS
    Chin Med J (Engl); 1989 Jul; 102(7):488-95. PubMed ID: 2576530
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of 482 cases of cervical spondylopathy by combining point-injection and needle-warming via moxibustion.
    Wang G; Qu F
    J Tradit Chin Med; 2001 Mar; 21(1):31-3. PubMed ID: 11360535
    [No Abstract]   [Full Text] [Related]  

  • 40. Twenty-eight cases of neuritis of lateral cutaneous nerve of thigh treated by acupuncture and point-injection.
    Liao M
    J Tradit Chin Med; 2001 Mar; 21(1):29-30. PubMed ID: 11360533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.